Medications not yet evaluated by P&T are considered NON-FORMULARY. Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step!
Please be sure to document all clinical activities daily.
Search results for:

fondaparinux

fondaparinux
Drug Name Form Strength Formulary Unrestricted Formulary Restricted Non-Formulary Interchange
Arixtra SOLUTION, SUBCUTANEOUS 2.5 mg/0.5 mL, 5 mg/0.4 mL, 7.5 mg/0.6 mL      
Arixtra SOLUTION, SUBCUTANEOUS 10 mg/0.8 mL, 12.5 mg/mL      
VIEW MORE Anticoagulants, Miscellaneous
CLASS
20120492
Comments:

Pharmacists (through PKS) may automatically order Anti-Xa levels on patients where LMWH dosing may be problematic (i.e., renal compromise, obesity, pregnancy, etc.), with follow-up physician communication.

Reviewed: October 30, 2007

Last updated: Dec. 29, 2016






This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.

Copyright © 2026 Rpharmy, LLC ­ All Rights Reserved